Evaluation of the humoral response induced by BBIBP-CorV vaccine by determining neutralizing antibodies in peruvian healthcare personnel.

Alonso Ricardo Soto-Tarazona Flor de Maria Charca-Rodriguez Mario Pareja-Medina Manuel G Fernández-Navarro Karina Altamirano-Cáceres Elizett Sierra Chávez Jarvis Raraz-Vidal Nestor Cabezudo-Pillpe Melissa Velarde-Rodríguez Andrés Martín Alcántara-Díaz

Published in: Revista peruana de medicina experimental y salud publica (2022)

All participants immunized with BBIBPCorV vaccine were positive for antibodies against the SARS-CoV-2 spike protein RBD. The correlation between the titer level and protection against COVID-19, as well as the length of the protection provided by the vaccine, needs to be evaluated.

Keyphrases

sars cov
healthcare
coronavirus disease
immune response
respiratory syndrome coronavirus
binding protein
small molecule
amino acid
zika virus